CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 45 enrolled
Drug / intervention
Maca Root +1 moredrug
Likely dose
Maca Root 3gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00568126
NCT00568126Phase 3Completed

A Double-Blind, Placebo Controlled Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females

Massachusetts General Hospital·interventional·Posted Dec 5, 2007·Updated Aug 26, 2020

In Brief

A Phase 3 clinical trial evaluating Maca Root and Placebo for Antidepressant Induced Sexual Dysfunction. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this study is to find out whether Maca Root is effective for treating sexual dysfunction in females that is caused by antidepressant drugs. An additional aim of the study is to document the safety and tolerability of maca root, as well as any potential side effects that it causes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 5, 2007
Enrollment StartDec 27, 2007
Primary CompletionOct 5, 2010
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 18.6 years ago

Interventions

Maca Rootdrug

3g/day of Maca Root for 12 weeks.

Placebodrug

Placebo provided by research pharmacy daily for 12 weeks.